These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Canakinumab for the Treatment of Autoinflammatory Recurrent Fever Syndromes. De Benedetti F; Gattorno M; Anton J; Ben-Chetrit E; Frenkel J; Hoffman HM; Koné-Paut I; Lachmann HJ; Ozen S; Simon A; Zeft A; Calvo Penades I; Moutschen M; Quartier P; Kasapcopur O; Shcherbina A; Hofer M; Hashkes PJ; Van der Hilst J; Hara R; Bujan-Rivas S; Constantin T; Gul A; Livneh A; Brogan P; Cattalini M; Obici L; Lheritier K; Speziale A; Junge G N Engl J Med; 2018 May; 378(20):1908-1919. PubMed ID: 29768139 [TBL] [Abstract][Full Text] [Related]
30. Colchicine as a potent anti-inflammatory treatment in COVID-19: can we teach an old dog new tricks? Deftereos S; Giannopoulos G; Vrachatis DA; Siasos G; Giotaki SG; Cleman M; Dangas G; Stefanadis C Eur Heart J Cardiovasc Pharmacother; 2020 Jul; 6(4):255. PubMed ID: 32337546 [No Abstract] [Full Text] [Related]
31. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543 [TBL] [Abstract][Full Text] [Related]
32. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. Grasselli G; Zangrillo A; Zanella A; Antonelli M; Cabrini L; Castelli A; Cereda D; Coluccello A; Foti G; Fumagalli R; Iotti G; Latronico N; Lorini L; Merler S; Natalini G; Piatti A; Ranieri MV; Scandroglio AM; Storti E; Cecconi M; Pesenti A; JAMA; 2020 Apr; 323(16):1574-1581. PubMed ID: 32250385 [TBL] [Abstract][Full Text] [Related]
33. A retrospective review of autoinflammatory diseases in Saudi children at a rheumatology clinic. Alenazi A; Al Sonbul A; Al Jumaah S; Al Mehaidib A; Al-Mayouf SM Ann Saudi Med; 2012; 32(1):43-8. PubMed ID: 22156639 [TBL] [Abstract][Full Text] [Related]
34. Children in Critical Care Due to Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Experience in a Spanish Hospital. García-Salido A; Leoz-Gordillo I; Martínez de Azagra-Garde A; Nieto-Moro M; Iglesias-Bouzas MI; García-Teresa MÁ; Cabrero-Hernández M; De Lama Caro-Patón G; Gochi Valdovinos A; González-Brabin A; Serrano-González A Pediatr Crit Care Med; 2020 Aug; 21(8):e576-e580. PubMed ID: 32459790 [TBL] [Abstract][Full Text] [Related]
35. Pearls from the Third Israeli Conference on FMF, other autoinflammatory disorders and AA amyloidosis. Livneh A; Ben-Zvi I Isr Med Assoc J; 2014 May; 16(5):269-70. PubMed ID: 24979827 [No Abstract] [Full Text] [Related]
36. Dosage Considerations for Canakinumab in Children With Periodic Fever Syndromes. Zhuang L; Chen J; Yu J; Marathe A; Sahajwalla C; Borigini M; Maynard J; Burckart GJ; Wang Y Clin Pharmacol Ther; 2019 Sep; 106(3):557-567. PubMed ID: 30447083 [TBL] [Abstract][Full Text] [Related]
37. Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept. Duret PM; Sebbag E; Mallick A; Gravier S; Spielmann L; Messer L Ann Rheum Dis; 2020 Sep; 79(9):1251-1252. PubMed ID: 32354772 [No Abstract] [Full Text] [Related]
38. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. Wiersinga WJ; Rhodes A; Cheng AC; Peacock SJ; Prescott HC JAMA; 2020 Aug; 324(8):782-793. PubMed ID: 32648899 [TBL] [Abstract][Full Text] [Related]
39. Tofacitinib for the treatment for colchicine-resistant familial Mediterranean fever: case-based review. Karadeniz H; Güler AA; Atas N; Satış H; Salman RB; Babaoglu H; Tufan A Rheumatol Int; 2020 Jan; 40(1):169-173. PubMed ID: 31813060 [TBL] [Abstract][Full Text] [Related]